Literature DB >> 3174027

Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa.

N S Peachey1, G A Fishman, D J Derlacki, K R Alexander.   

Abstract

Carriers of X-linked retinitis pigmentosa were studied using electroretinographic and psychophysical procedures. Under both dark- and light-adapted (cone-isolated) conditions, electroretinogram (ERG) a-waves of carriers were reduced in amplitude but normal in implicit time, whereas b-waves were reduced in amplitude and delayed in implicit time. Reductions in b-wave amplitudes of the carriers as a group were equivalent for the rod and cone systems. Luminance-response functions for both dark-adapted and cone-isolated b-waves were fit by the Naka-Rushton equation and demonstrated a selective reduction of Rmax; the semi-saturation constant (K) and the slope parameter (n) were normal. Electroretinograms recorded using the brightest stimulus flashes were most effective at distinguishing carriers from normals. Absolute thresholds of the carriers were elevated significantly across the central 40 degrees of the visual field. As a group, the threshold elevations of the carriers were approximately equal for the rod and cone systems.

Entities:  

Mesh:

Year:  1988        PMID: 3174027     DOI: 10.1016/s0161-6420(88)33128-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6.

Authors:  Thaddeus P Dryja; Terri L McGee; Eliot L Berson; Gerald A Fishman; Michael A Sandberg; Kenneth R Alexander; Deborah J Derlacki; Aruna S Rajagopalan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

2.  Optical coherence tomography and electro-oculogram abnormalities in X-linked retinitis pigmentosa.

Authors:  Enzo Maria Vingolo; Maria Luisa Livani; D Domanico; Regina H F Mendonça; Eduardo Rispoli
Journal:  Doc Ophthalmol       Date:  2006-09-06       Impact factor: 2.379

3.  Intensity response function of the photopic negative response (PhNR): effect of age and test-retest reliability.

Authors:  Nabin R Joshi; Emma Ly; Suresh Viswanathan
Journal:  Doc Ophthalmol       Date:  2017-05-15       Impact factor: 2.379

4.  ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave.

Authors:  Mary A Johnson; Brett G Jeffrey; André M V Messias; Anthony G Robson
Journal:  Doc Ophthalmol       Date:  2019-03-30       Impact factor: 2.379

5.  Comparison of three methods of estimating the parameters of the Naka-Rushton equation.

Authors:  L S Evans; N S Peachey; A L Marchese
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  X-linked dominant cone-rod degeneration: linkage mapping of a new locus for retinitis pigmentosa (RP 15) to Xp22.13-p22.11.

Authors:  R E McGuire; L S Sullivan; S H Blanton; M W Church; J R Heckenlively; S P Daiger
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

7.  Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis.

Authors:  Sirichai Pasadhika; Gerald A Fishman; Edwin M Stone; Martin Lindeman; Ruth Zelkha; Irma Lopez; Robert K Koenekoop; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

8.  Peripapillary retinal nerve fiber layer thinning in patients with autosomal recessive cone-rod dystrophy.

Authors:  Sirichai Pasadhika; Gerald A Fishman; Rando Allikmets; Edwin M Stone
Journal:  Am J Ophthalmol       Date:  2009-05-05       Impact factor: 5.258

9.  Spontaneous improvement of rod system function in a patient with melanoma-associated retinopathy.

Authors:  Linda S Kim; Kenneth R Alexander; Gerald A Fishman
Journal:  Retin Cases Brief Rep       Date:  2008

10.  Diagnosis in a patient with fundus albipunctatus and atypical fundus changes.

Authors:  Manal Hajali; Gerald A Fishman; Thaddeus P Dryja; Meredith O Sweeney; Martin Lindeman
Journal:  Doc Ophthalmol       Date:  2008-10-24       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.